Skip to content
★ Sign in to follow
Asymchem Laboratories (Tianjin) Co., Ltd. logo

Asymchem Laboratories (Tianjin) Co., Ltd. Stock: price and insider trades · China

凯莱英

CN·Mcap CN¥55.6BHealth Care

No insider purchase over the last 90 days. The latest, by 徐向科, was filed 13 Sept 2024.

Asymchem Laboratories (Tianjin) Co., Ltd.: what insiders have been doing

Asymchem Laboratories (Tianjin) Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Asymchem Laboratories (Tianjin) Co., Ltd. The previous disclosure was published on 13 September 2024.

Looking back to 2021, when coverage begins, insiders filed 2 purchases and 4 sales.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€629,112
2 ops. · all time
Sell Volume
€2M
4 ops. · all time

Since the insiders bought

  • Filed 13 Sept 2024 · 788 days ago · €28k
    +85.9%
    Entry CN¥62.77 · Close at T+365 CN¥116.69
  • Filed 12 Sept 2024 · 789 days ago · €601k
    +82.7%
    Entry CN¥63.88 · Close at T+365 CN¥116.69

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Asymchem Laboratories (Tianjin) Co., Ltd. Buy (bullish), based on 10 analysts. Average price target: CN¥188.84.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 13,630 of 26,911 companies
51.1
score / 100
Value
32
Quality
71
FCF yld0.2%
Earn yld2.0%
EV/EBITDA30.2x
ROE5.9%
Gross mgn42%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥153.58
Analyst consensus
10 analysts
Buy
CN¥160.00Target CN¥188.84(+23%)CN¥234.65
Income statement
RevenueCN¥6.7B
Gross profitCN¥2.8B42% margin
EBITDACN¥1.8B28% margin
Net incomeCN¥1.1B14.6% margin
Valuation
PER (trailing)52.4x
PER (forward)30.1x
P/Book3.1x
Beta0.19
Balance sheet & cash
Market capCN¥55.6B
Total debtCN¥309.2M
Free Cash FlowCN¥137.2M
Debt / Equity2%
Profitability & ownership
ROE5.9%
ROA3.6%
% insiders41.0%
% institutions24.6%
Last declaration on 13 September 2024
Declarations6 total
  • ▲
    董秘,高管Executives
    223,580 CNY23SZSE
    3,500 shares4.3% of flowA股XSHESZSE:173000008103763940
    Canonical exit: 12 Dec 2024 (T+90)
  • ▲
    董事,高管Executives
    5M CNY15SZSE
    74,000 shares100.0% of flowA股XSHESZSE:173000008096655840
    Canonical exit: 11 Dec 2024 (T+90)
  • ▼
    董秘,高管Executives
    5M CNY34SZSE
    11,000 shares95.7% of flowA股XSHESZSE:173000005210335600
  • ▼
    副总经理Executives
    1M CNY37SZSE
    3,400 shares26.3% of flowA股XSHESZSE:173000005680485540
  • ▼
    副总经理Executives
    5M CNY30SZSE
    11,300 shares100.0% of flowA股XSHESZSE:173000004840101860
  • ▼
    高管Executives
    4M CNY18SZSE
    11,000 shares73.7% of flowA股XSHESZSE:173000004566340830

6 of 6 declarations

About Asymchem Laboratories (Tianjin) Co., Ltd.

凯莱英 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations